An observational study in Abdominal Pain and Quality of Life, sponsored by Oslo University Hospital. Status unknown at 1 site in Norway. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-11-24.
Sponsored by Oslo University Hospital · Observational
Exploration of abdominal pain post sleeve gastrectomy in morbid obese patients
The primary aim is to evaluate abdominal pain in morbid obese patients before and after sleeve gastrectomy. The investigators will especially focus on chronic abdominal pain, and its relation to quality of life and weight loss. In a sub-analysis the investigators will compare the findings of the present cohort with patients operated with Roux-en-Y gastric bypass.
Primary endpoints/outcomes:
Secondary endpoints/outcomes:
387 studies on the registry are indexed under Abdominal Pain; 58 are open to participants now.
This study's planned enrollment of 250 is above the median of 127 across 80 observational studies indexed under Abdominal Pain.
Browse Abdominal Pain studies →Oslo University Hospital is the lead sponsor of 834 studies on the registry; 149 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients scheduled for sleeve gastrectomy for morbid obesity at Oslo University Hospital and Voss sykehus
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients undergoing sleeve gastrectomy at the Center for Morbid Obesity and Bariatric Surgery, Oslo University Hospital and a collaborating center.
Patients who dont understand Norwegian language
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic abdominal pain 2 years after gastric sleeve
questionnaire
Time frame: 2 years
Quality of life related to abdominal pain and symptoms
questionnaire (SF-36v2, OP scale)
Time frame: 2 years
Comparison to gastric bypass
questionnaire (SF36v2, OP scale)
Time frame: 2 year
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2015 to primary completion in Aug 2020, 57 months.
Of 28 non-industry observational studies under Abdominal Pain, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 38. This study's 57 months is above that.
Counting every sponsor, half of 37 studies reached it within 16 months; a quarter within 7 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.